Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment
Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment have?
Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment has 77 citations in the OpenAlex counts ScholarIQ stores.
When was Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment published?
Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment has 2024 year in the ScholarIQ index.
What is the open-access status of Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment?
Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment has gold oa status in the ScholarIQ index.
What is the DOI of Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment?
The DOI for Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment is on the source record.
What is the PMID of Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment?
The PMID for Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment is on the source record.
What is the OpenAlex record for Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment?
The OpenAlex for Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment is on the source record.